Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1,390,020
-
Number of holders
-
10
-
Total 13F shares, excl. options
-
282,070
-
Shares change
-
-156,819
-
Total reported value, excl. options
-
$894,000
-
Value change
-
-$561,407
-
Number of buys
-
3
-
Number of sells
-
-6
-
Price
-
$3.17
Significant Holders of Arcadia Biosciences, Inc. - Common Stock (RKDA) as of Q4 2018
14 filings reported holding RKDA - Arcadia Biosciences, Inc. - Common Stock as of Q4 2018.
Arcadia Biosciences, Inc. - Common Stock (RKDA) has 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 282,070 shares
of 1,390,020 outstanding shares and own 20% of the company stock.
Largest 10 shareholders include SABBY MANAGEMENT, LLC (95,682 shares), Anson Funds Management LP (55,261 shares), BANK OF MONTREAL /CAN/ (40,000 shares), Virtu Financial LLC (25,645 shares), DIMENSIONAL FUND ADVISORS LP (22,942 shares), OXFORD ASSET MANAGEMENT LLP (22,241 shares), Vanguard Group Inc (18,655 shares), Advisor Group, Inc. (1,000 shares), SeaCrest Wealth Management, LLC (425 shares), and BlackRock Inc. (219 shares).
This table shows the top 10 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.